Gene · 117
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophils contribute to elevated BAFF levels to modulate adaptive immunity in patients with primary immune thrombocytopenia by CD62P and PSGL1 interaction. | Clin Transl Immunology | 2022 | 35782911 | PubTator, text mining | PubMed |
| Relationship between Plasma Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Level and Proteome Profile of Cows. | Animals (Basel) | 2022 | 35739894 | PubTator, text mining | PubMed |
| Adrenal Stress Hormone Regulation of Hepatic Homeostatic Function After an Acute Ozone Exposure in Wistar-Kyoto Male Rats. | Toxicol Sci | 2022 | 35737395 | PubTator, text mining | PubMed |
| Low-dose interleukin-2 reverses chronic migraine-related sensitizations through peripheral interleukin-10 and transforming growth factor beta-1 signaling. | Neurobiol Pain | 2022 | 35733705 | PubTator, text mining | PubMed |
| The PACAP Paradox: Dynamic and Surprisingly Pleiotropic Actions in the Central Regulation of Energy Homeostasis. | Front Endocrinol (Lausanne) | 2022 | 35721722 | PubTator, text mining | PubMed |
| Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma. | Front Genet | 2022 | 35719378 | PubTator, text mining | PubMed |
| miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma. | Int J Endocrinol | 2022 | 35719192 | PubTator, text mining | PubMed |
| Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells. | Drug Deliv | 2022 | 35708464 | PubTator, text mining | PubMed |
| Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4-Mediated Thrombin Resistance. | Arterioscler Thromb Vasc Biol | 2022 | 35708029 | PubTator, text mining | PubMed |
| Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation. | Sci Rep | 2022 | 35701444 | PubTator, text mining | PubMed |
| Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study. | BMC Cancer | 2022 | 35698045 | PubTator, text mining | PubMed |
| The pituitary adenylate cyclase-activating polypeptide system as a sex-specific modulator of hippocampal response to threat stimuli. | Neurobiol Stress | 2022 | 35685680 | PubTator, text mining | PubMed |
| Variation in Platelet Activation State in Pre-Donation Whole Blood: Effect of Time of Day and ABO Blood Group. | J Blood Med | 2022 | 35685305 | PubTator, text mining | PubMed |
| Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications. | Int J Mol Sci | 2022 | 35682744 | PubTator, text mining | PubMed |
| Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs. | Front Mol Biosci | 2022 | 35677880 | PubTator, text mining | PubMed |
| Role of Catestatin in the Cardiovascular System and Metabolic Disorders. | Front Cardiovasc Med | 2022 | 35665253 | PubTator, text mining | PubMed |
| Homophilic Interaction Between Transmembrane-JAM-A and Soluble JAM-A Regulates Thrombo-Inflammation: Implications for Coronary Artery Disease. | JACC Basic Transl Sci | 2022 | 35663628 | PubTator, text mining | PubMed |
| Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength. | Platelets | 2022 | 35659185 | PubTator, text mining | PubMed |
| The Role of Platelet-Selectin as a Marker of Thrombocyte Aggregation on Cerebral Sinus Venous Thrombosis. | J Blood Med | 2022 | 35642190 | PubTator, text mining | PubMed |
| Human Platelets Contain, Translate, and Secrete Azurocidin; A Novel Effect on Hemostasis. | Int J Mol Sci | 2022 | 35628475 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/117/papers?page=17